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 
Abstract—Among their multitude of physiological and 
behavioral effects, the neurochemicals serotonin (5-HT) and 
orexin (Ox) have been closely linked to major depressive 
disorders (MDD) and sleep alterations. The dorsal raphe 
nucleus (DRN) and the lateral hypothalamus area (LHA) are 
brain regions that are sources of 5-HT and Ox, and there is 
evidence that suggests a reciprocal interaction between them. 
This lends support to the hypothesis of a close relationship 
between MDD and sleep disorders. Based on various 
experimental data, and appropriate assumptions, we construct a 
mathematical model of the coupled DRN-LHA neural circuit. 
Our model relates the dynamics of four important variables that 
can be experimentally measured: (i) the firing rate of 5-HT-
containing neurons in DRN, (ii) the firing rate of Ox-containing 
neurons in the LHA, (iii) 5-HT concentration level in LHA, and 
(iv) Ox concentration level in DRN. Simulations show that our 
model supports the co-existence of baseline activities and 
concentration levels as observed in various separate 
experiments. It also allows circuit-level exploration of various 
parameters not yet identified experimentally, e.g. the rise and 
decay of Ox concentration levels due to Ox neural activity, and 
the exact dependence of Ox neural activity on 5-HT level. 
Finally we have made some model predictions regarding the 
effects of the 5-HT antagonist on the circuit. Our model, which 
can be subjected to verification and refinement as new 
experimental data accumulates, provides unified quantitative 
relationships and predictions between two important connected 
brain regions strongly tied to MDD and sleep disorders.  
 
I. INTRODUCTION 
 
The lateral hypothalamic area (LHA) of the brain is linked 
to the hypothalamic-pituitary-adrenal (HPA) axis, which is a 
major part of the neuroendocrine system that regulates a host 
of behaviours including sleep-wake cycle, reaction to stress, 
digestion, mood and emotions, and energy storage and 
expenditure [1], [2]. Neurons in the LHA transmit orexin 
(Ox) peptide which is known for its important role in sleep 
disorders such as narcolepsy [3].   
A nearby brain region, the dorsal raphe nucleus (DRN) is 
a major source of the neurochemical serotonin (5-HT) that 
regulates mood and emotion and its abnormal activity is 
linked to psychiatric disorders such as major depressive 
disorder (MDD) [4].  
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Fragmented and reduced slow wave sleep, non rapid eye 
movement (NREM), insomnia at all the stages of sleep and 
rapid eye movement (REM) anomalies are some of the most 
commonly observed features in MDD [5]. There is also 
increasing evidence from physiological studies that suggests 
reciprocal connections between LHA and DRN [6], [7]. 
However, there are only a few experimental studies of the 
LHA-DRN circuitry.  
Most of the modeling work in this area focuses on two 
specific frameworks; one that combines the interaction 
between sleep homeostasis and the circadian system, and one 
based on the interaction of abstract multiple oscillators [8], 
[9]. However, these models do not provide details of the 
underlying neuronal mechanisms responsible for the 
pathogenesis of sleep and mood disorder. More importantly, 
none investigated the LHA-DRN circuit. Thus, in this paper, 
we use experimental data (where available) to build a 
mathematical model of this neural circuit and explore the 
dynamical relationship between 5-HT and Ox systems. 
Where appropriate experimental data is available we make 
sensible assumptions and projections. A “firing-rate” type 
model formalism (Figure 1A, B) is adopted to minimizes the 
number of free parameters in the model while allowing us to 
efficiently and rigorously explore the effects of these few 
unknown parameters on the overall circuit dynamical state.  
The organization of the paper is as follows. Section II will 
discuss how the model is constructed. Section III will discuss 
the simulation results by varying the model free parameters 
and will demonstrate an example on simulating the effects of 
an antagonist on the circuit. Finally, Section IV presents the 
conclusions and discusses future work.   
 
II. MODEL CONSTRUCTION 
 
Electrophysiological recordings from Ox neurons in the 
LHA and 5-HT neurons in the DRN of rats and Enhanced 
Green Fluorescent Protein (EGFP) mice have revealed that 
5-HT hyperpolarizes the Ox neurons, while Ox depolarizes 
the 5-HT neurons in a concentration dependent manner [10], 
[11], [12]. These experiments show the concentration 
response relationship between the applied neurotransmitter 
and the neuronal firing rate. Thus, we incorporate a similar 
approach (Figure 1A, B) for the construction of a simplified 
LHA-DRN circuitry.  
The LHA or DRN neurons are assumed to be 
homogeneous and any change in the concentration level of 
Ox ([Ox]) can affect the population firing rate of 5-HT 
neurons in DRN (fDRN). Similarly, any alteration in the 5-HT 
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concentration ([5-HT]) levels can affect the population firing 
rate of Ox neurons in LHA (fLHA) (Figure 1B).  
 
 
 
 
 
 
 
 
 
 
 
Due to lack of available experimental data, we construct 
the model by considering the following constraints and 
assumptions (which can be verified in future experiments):  
 
(i) The specific types of Ox peptides (Ox A or Ox B) are not 
considered in this model as the concentrations dependent 
change in the fDRN is almost same for both types [11]. 
(ii) The baseline concentration level of Ox (10pg/mg~      
2.8 nM) at midbrain and DRN are the same [6].  
(iii) The firing rates of 5-HT and Ox neurons are assumed to 
be in the range of 0-10 Hz [10], [11], [12] and [5-HT], [Ox] 
concentrations are in the range of  0-5 nM [6], [13] as 
observed in experiments. 
(iv) The timescales of the effects of [5-HT] and [Ox] on 
neurons in LHA and DRN are estimated to be [Ox] ~ 1 min 
and [5-HT] ~ 10 sec, respectively. These are estimated from 
the effective effects of Ox and 5-HT on the firing-rate 
histogram time courses of the neurons [10], [14].  
(v) Autoreceptors and other neuronal types are ignored.  
Experimental evidence suggests that the LHA-to-DRN 
connection is excitatory, while the DRN-to-LHA connection 
is inhibitory (Figure 1A) [7]. The dynamical equations 
describing the population firing rates of the two pools of 
neurons are:                                         
               ])([ [Ox] OxFf
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for the LHA-DRN connection, and for the DRN-LHA 
connection,   
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where [Ox]/[5-HT] is the time constant for Ox and 5-HT effects 
on the fDRN and fLHA, respectively. FLHA ([5-HT]) or         
FDRN ([Ox]) is the input-output function between the            
5-HT/Ox concentration and the firing rate of LHA/DRN 
neurons. The input-output function for DRN, FDRN ([Ox]) is 
easily fitted from the available experimental data          
(Figure 1 B, left) [11]. However, due to unavailable data, we 
estimate FLHA ([5-HT]) from different experimental data 
(Figure 1B, right) by constraining the basal values of         
[5-HT] ~ 1.6 nM and fLHA ~ 5 Hz [10], [12], [13].  
These estimated input-output functions are:  
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where the parameters K1= 2.0732 and K2= 0.2041 control 
the lateral shift in the input-output functions, and the third 
free parameter S = 0.10 controls the slope of the function in 
(4). These values are used as control. 
To close the loop in the model circuit construction, the 
next important aspect is to incorporate the release-and- 
reuptake dynamics for [5-HT] in LHA and [Ox] in DRN. 
Fortunately for [5-HT], we use the established model [15] 
with a slight modification:   
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where [5-HT]P is the release per stimulus frequency 
artificially stimulated, and the reuptake rate (right most term) 
is approximated by a Michaelis-Menten equation. The 
maximum reuptake rate Vmax and Km are constants. Note that 
we have replaced the artificial stimulus frequency with fDRN 
in (5) by assuming their linear proportionality, and by 
modifying [5-HT]P = 33.57 nM so that at basal steady state in 
an isolated DRN population, [5-HT] ~ 1.6 nM [13].   
Similar [Ox] release-and-decay dynamics is not 
straightforward due to unavailable experimental data. 
Therefore, we assume the simplest form of equation 
governing such dynamics:  
 
                 ][
][
Oxf
dt
Oxd
LHA              )6(  
where the free parameters decay rate ()=0.91/s and the rise 
factor (α)=0.77 nM are associated with the reuptake process 
and linear dependence on fLHA, respectively. Note that, by 
definition, 1/ < [Ox] ~ 1 min, acting as a constraint.  
A forward Euler numerical scheme is used with a time 
step of 1ms to numerically integrate (1-6). The free 
parameters are tuned such that the control baseline values are 
Fig. 1.  A: Network model architecture. Circle (arrow): effective inhibitory 
(excitatory) connections [7]. B: Input-output functions for 5-HT neurons 
in DRN (left, cf. [11]) and Ox neurons in LHA (right) (for different slopes 
discussed in detail in III D, [10], [12]. C: Single-trial transient firing rates 
and concentration levels in the control condition. Note: Bottom two panels 
are transient trajectories with initial condition [Ox] = 2.8 nM, fDRN = 0.5 
Hz, [5-HT] =1.6 nM and fOx = 5 Hz.  
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close to those in experiments (section IIIA). Simulation 
results are discussed in the following section.  
III. SIMULATION RESULTS 
A. Baseline firing rates and concentration levels 
Under the control condition, we integrate (1-6) towards 
their steady state values. Figure 1C shows the transient 
dynamics of the four variables in a single simulation. Except 
for the initial fast transient of [Ox], most of the timecourse 
exhibit slows dynamics, most likely slaved to the slow 
timescale of [Ox] ~ 1 min. All the variables eventually ascend 
or descend towards reasonable baseline values ([Ox] =2.79 
nM, fDRN= 0.58 Hz, [5-HT] = 1.88 nM and fOx= 3.30 Hz). 
Note the interesting non-monotonic trajectory within the 
fDRN-vs-[Ox] phase space (Figure 1C, bottom left panel), 
probably reflecting a brief initial adjustment period towards 
a steady state. This is due to the existence of some slow-fast 
dynamics. In the rest of the work (subsections B-C), we will 
focus on how the system’s steady state varies with the three 
free parameters and plausible effects from 5-HT antagonist.  
B. Decay Rate of Orexin Concentration in LHA 
After identifying the control conditions, we fixed all the 
free parameters except the decay rate of the orexin 
concentration (LHA). From the simulations, we found that as 
the decay rate increases the steady state of Ox, 5-HT and 
DRN firing rate decreases and LHA firing rate increases       
(Figure 2A). 
This relationship can be explained by the LHA-DRN 
feedback loop circuitry; due to the excitatory connection 
from LHA to DRN, the increase in the Ox decay rate 
decreases [Ox] in DRN and thus the firing rate of the DRN 
neurons decreases. This decrease in the DRN firing rate 
cause a decrease in the [5-HT] level at LHA, and provides a 
weaker inhibitory effect on LHA neurons, which eventually 
contribute to the increase in the firing rate of LHA neurons 
(Figure 2A). From these results, we can conclude that          
5-HT/Ox levels are positively correlated while LHA/DRN 
firing rates are negatively correlated (Figure 2B). 
 
C. Rise Factor of Orexin Concentration in LHA 
    The other unknown parameter is the rise factor that 
signifies the per stimulus release of extracellular orexin [Ox] 
in the DRN. From our simulations, we found that as we 
increases the rise factor the concentration levels of [Ox],     
[5-HT] and DRN firing rate increases and LHA firing rate 
decreases. These trends can be explained by the LHA-DRN 
feedback loop circuitry in a similar way as discussed in 
section III B.   
 
 
 
 
 
D. Slope of Input-output Function in LHA 
 
The next unknown parameter of the model is the slope (S) 
defined for the input-output function of LHA (equation 4). 
The simulations results (Figure 4A) show that any positive 
change in slope increases the value of all the model variables 
(concentration of 5-HT/Ox and firing rate LHA/DRN). 
However, an increase in slope beyond a particular point does 
not significantly affect the circuit dynamics. From these 
results we can deduce that both the concentrations and firing 
rate are positively correlated (Figure 4B). 
 
 
 
Fig. 2.  Effects of decay rate of orexin concentration [Ox] on firing 
rates and concentration levels in the circuit. A: Steady-state values. 
B: Deduced relationships from A.  
Fig. 3.  Effects of rise factor of orexin concentration [Ox] on firing rates 
and concentration levels in the circuit. A and B: as in Fig. 2.  
 
 
 
 
 
 
 
Fig. 4.  Effects of slope of the LHA input-output function on the 
firing rates and concentration levels in the circuit. A and B: as in 
Fig2.  
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E. Effects of a Serotonin Antagonist 
 
Having explored the free model parameters, we shall now 
demonstrate how we can implement and simulate the effects 
of an antagonist on the circuit.  
According to [11], Ox antagonists laterally shift the input-
output function of 5-HT neurons in DRN rightward. This is 
similar for 5-HT on orexin neurons in LHA. We have 
modeled the effective shift due to antagonist by varying the 
parameter K1 and K2 in (3, 4), assuming that the release-and-
reuptake dynamics of 5-HT and Ox is unchanged.  
As an example, we show in Figure 5 results for a 5-HT 
antagonist. Similar implementations and results hold for the 
5-HT agonist, and Ox agonist/antagonist (not shown).  
 
 
 
 
 
 
IV. DISCUSSIONS AND CONCLUSIONS 
 
We have built a mathematical model of a mutually 
coupled LHA-DRN circuit based on various known 
experimental data. The model is useful for evaluating 
quantitatively and efficiently both the transient and steady-
state relationships among four important, interdependent and 
experimentally measurable quantities – fLHA, fDRN, [Ox] and 
[5-HT]. Although we have used the experimental data from 
separate experiments, our model unifies these data and 
supports the co-existence of the observed baseline values of 
these four variables.  
The model is built upon the assumptions of the not yet 
identified release-and-decay mechanism of [Ox] and the 
fLHA-[5-HT] relationship. We have explored three free 
parameters to study their effects on the circuit’s steady state. 
These simulated data are used to correlate the system’s four 
measurable variables (e.g. relationship between [Ox] and   
[5-HT], and between fLHA and fDRN), constituting our model’s 
predictions. Interestingly within the range of the various 
parameters that we have varied, we always find [Ox] to be 
linearly related to [5-HT], even though the firing rate-vs-
concentration functions are nonlinear. Additionally, we have 
implemented and studied the serotonin antagonist’s effects 
on the circuit.  
Our work constitutes a first step in modeling the         
LHA-DRN circuit. The model is sufficiently simple to allow 
refinements when more experimental data becomes 
available. We are planning to include more realistic features 
and other local neuronal types such as GABAergic 
interneurons. As the model matures, we will begin to 
incorporate it into established mathematical models of the 
sleep-wake cycle [8] to study the connections between sleep-
wake patterns and serotonin levels, the latter being linked to 
depression. This approach may also allow us to quantify 
antidepressant drug (SSRI) effects on sleep patterns or 
disorder. In summary, we have established a useful 
mathematical model of an important brain circuit that can 
reveal potential insights into the relationships among 
depression, antidepressants, and sleep disorders.  
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